Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | 4015995 | — |
Measles PCR+; This spontaneous report was received from an unspecified health care professional on 16-MAY-2025 and refers to a Child male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-APR-2025, the patient was vaccinated with a first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (Batch/Lot number 4015995 is an invalid batch/lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live , expiration date reported as 24-SEP-2026), (dose, frequency, anatomical location, and route of administration were not reported) and with a first dose of sterile diluent (MERCK STERILE DILUENT), (dose, frequency, anatomical location, route of administration, lot#, expiration date and indication were not reported) for prophylaxis at Clinic. On 10-MAY-2025, the patient presented to the emergency department with fever, rash, wheezing, and cough, and was confirmed measles Polymerase Chain Reaction (PCR) positive, on 15-MAY-2015 (Measles). They would submit the specimen for Measles Virus Genotype A Realtime -qPCR (MeVA) testing to confirm it is vaccine strain as soon as the specimen arrived at their state lab." At the reporting time, the outcome of Measles was unknown. The reporter considered the event unknown to Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) and sterile diluent (MERCK STERILE DILUENT). Lot # will be requested and will be submitted if received. This is one of several reports from the same source.
Merck sterile diluent
Test Date: 20250515; Test Name: measles PCR+; Test Result: Positive ; Result Unstructured Data: measles PCR+